Japan MHLW Tables Review For Avastin Breast Cancer Indication
This article was originally published in PharmAsia News
Executive Summary
At its August 1 meeting, the Second Subcommittee on New Drugs at Japan's Ministry of Health, Labor and Welfare decided to continue discussions on whether to recommend approval for Chugai Pharmaceutical's Avastin (bevacizumab) in the additional indication of metastatic breast cancer